Puma Biotechnology licenses with CANbridge to commercialize NERLYNX in China
Biopharmaceutical company focused on developing Western drug candidates in China and North Asia, CANbridge Life Sciences undertakes licensing agreement to develop and commercialize…
Read More...
Read More...
